157 related articles for article (PubMed ID: 38197640)
21. Human Metapneumovirus Reinfection in Aged Mice Recapitulates Increased Disease Severity in Elderly Humans Infected with Human Metapneumovirus.
Parks OB; Eddens T; Zhang Y; Oury TD; McElroy A; Williams JV
Immunohorizons; 2023 Jun; 7(6):398-411. PubMed ID: 37261717
[TBL] [Abstract][Full Text] [Related]
22. Immunization with a recombinant bacillus Calmette-Guerin strain confers protective Th1 immunity against the human metapneumovirus.
Palavecino CE; Céspedes PF; Gómez RS; Kalergis AM; Bueno SM
J Immunol; 2014 Jan; 192(1):214-23. PubMed ID: 24319265
[TBL] [Abstract][Full Text] [Related]
23. Human metapneumovirus infection activates the TSLP pathway that drives excessive pulmonary inflammation and viral replication in mice.
Lay MK; Céspedes PF; Palavecino CE; León MA; Díaz RA; Salazar FJ; Méndez GP; Bueno SM; Kalergis AM
Eur J Immunol; 2015 Jun; 45(6):1680-95. PubMed ID: 25763996
[TBL] [Abstract][Full Text] [Related]
24. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
[TBL] [Abstract][Full Text] [Related]
25. Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System.
Soto JA; Gálvez NMS; Benavente FM; Pizarro-Ortega MS; Lay MK; Riedel C; Bueno SM; Gonzalez PA; Kalergis AM
Front Immunol; 2018; 9():2466. PubMed ID: 30405642
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of Human Metapneumovirus M2-1 Protein Upregulates Viral Replication and Pathogenesis.
Cai H; Zhang Y; Lu M; Liang X; Jennings R; Niewiesk S; Li J
J Virol; 2016 Aug; 90(16):7323-7338. PubMed ID: 27252537
[TBL] [Abstract][Full Text] [Related]
27. Protective Role of Nuclear Factor Erythroid 2-Related Factor 2 Against Respiratory Syncytial Virus and Human Metapneumovirus Infections.
Ivanciuc T; Sbrana E; Casola A; Garofalo RP
Front Immunol; 2018; 9():854. PubMed ID: 29740449
[TBL] [Abstract][Full Text] [Related]
28. Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.
González AE; Lay MK; Jara EL; Espinoza JA; Gómez RS; Soto J; Rivera CA; Abarca K; Bueno SM; Riedel CA; Kalergis AM
Virulence; 2017 Aug; 8(6):685-704. PubMed ID: 27911218
[TBL] [Abstract][Full Text] [Related]
29. Role of human metapneumovirus glycoprotein G in modulation of immune responses.
Velayutham TS; Ivanciuc T; Garofalo RP; Casola A
Front Immunol; 2022; 13():962925. PubMed ID: 35958551
[TBL] [Abstract][Full Text] [Related]
30. Cell-Mediated Responses to Human Metapneumovirus Infection.
Ballegeer M; Saelens X
Viruses; 2020 May; 12(5):. PubMed ID: 32423043
[TBL] [Abstract][Full Text] [Related]
31. Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice.
Darniot M; Pitoiset C; Petrella T; Aho S; Pothier P; Manoha C
J Virol; 2009 Apr; 83(7):3323-32. PubMed ID: 19144706
[TBL] [Abstract][Full Text] [Related]
32. Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice.
Soto JA; Gálvez NMS; Pacheco GA; Canedo-Marroquín G; Bueno SM; Kalergis AM
Front Cell Infect Microbiol; 2021; 11():662714. PubMed ID: 34268134
[TBL] [Abstract][Full Text] [Related]
33. Viral acute lower respiratory infections impair CD8+ T cells through PD-1.
Erickson JJ; Gilchuk P; Hastings AK; Tollefson SJ; Johnson M; Downing MB; Boyd KL; Johnson JE; Kim AS; Joyce S; Williams JV
J Clin Invest; 2012 Aug; 122(8):2967-82. PubMed ID: 22797302
[TBL] [Abstract][Full Text] [Related]
34. MyD88 controls human metapneumovirus-induced pulmonary immune responses and disease pathogenesis.
Ren J; Kolli D; Deng J; Fang R; Gong B; Xue M; Casola A; Garofalo RP; Wang T; Bao X
Virus Res; 2013 Sep; 176(1-2):241-50. PubMed ID: 23845303
[TBL] [Abstract][Full Text] [Related]
35. Emergence and Potential Extinction of Genetic Lineages of Human Metapneumovirus between 2005 and 2021.
Groen K; van Nieuwkoop S; Meijer A; van der Veer B; van Kampen JJA; Fraaij PL; Fouchier RAM; van den Hoogen BG
mBio; 2023 Feb; 14(1):e0228022. PubMed ID: 36507832
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of human metapneumovirus genotypes and genotype-specific seroprevalence in Yamagata, Japan.
Matsuzaki Y; Itagaki T; Abiko C; Aoki Y; Suto A; Mizuta K
J Med Virol; 2008 Jun; 80(6):1084-9. PubMed ID: 18428137
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and molecular epidemiology of human metapneumovirus in children with acute lower respiratory tract infections in China, 2017 to 2019: A multicentre prospective observational study.
Zhao H; Feng Q; Feng Z; Zhu Y; Ai J; Xu B; Deng L; Sun Y; Li C; Jin R; Shang Y; Chen X; Xu L; Xie Z
Virol Sin; 2022 Dec; 37(6):874-882. PubMed ID: 36007839
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.
Herd KA; Nelson M; Mahalingam S; Tindle RW
J Gen Virol; 2010 May; 91(Pt 5):1302-10. PubMed ID: 20053825
[TBL] [Abstract][Full Text] [Related]
39. Human Metapneumovirus Infection in Chronic Obstructive Pulmonary Disease: Impact of Glucocorticosteroids and Interferon.
Kan-O K; Ramirez R; MacDonald MI; Rolph M; Rudd PA; Spann KM; Mahalingam S; Bardin PG; Thomas BJ
J Infect Dis; 2017 May; 215(10):1536-1545. PubMed ID: 28379462
[TBL] [Abstract][Full Text] [Related]
40. Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.
Deffrasnes C; Hamelin ME; Prince GA; Boivin G
Antimicrob Agents Chemother; 2008 Jan; 52(1):279-87. PubMed ID: 17967906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
